Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU2-44P (RNA, U2 small nuclear 44, pseudogene) is a noncoding genomic locus identified in humans and mapped to chromosome 4[6]. It is designated as a pseudogene, meaning it does not produce a functional U2 small nuclear RNA molecule. Functional U2 snRNAs are integral to the spliceosome complex and responsible for the splicing of precursor messenger RNA, but this specific pseudogene does not encode a functional product and has no recognized physiological or pathological role[6][1]. No therapeutic or diagnostic relevance has been associated with RNU2-44P.
None (Not druggable, no mechanism of action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 44, pseudogene (RNU2-44P).